The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis

Published:2022-02 Issue: Volume:61 Page:77-83
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Kim Hee Jeong,Kim Seonok^ORCID,Freedman Rachel A.,Partridge Ann H.

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference47 articles.

1. Trends in breast cancer mortality by stage at diagnosis among young women in the United States;Guo;Cancer,2018

2. Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial;Partridge;J Clin Oncol: official journal of the American Society of Clinical Oncology,2013

3. The relation between survival and age at diagnosis in breast cancer;Adami;N Engl J Med,1986

4. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women;N Engl J Med,1988

5. The development of endocrine therapy for women with breast cancer;Sainsbury;Cancer Treat Rev,2013

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of tamoxifene-controlled ovarian hyperstimulation for fertility preservation before breast cancer treatment: A prospective cohort study with a 5-year follow-up;The Breast;2024-10

2. Hormone receptor-positive early breast cancer in young women: A comprehensive review;Cancer Treatment Reviews;2024-09

3. Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers;Annals of Oncology;2024-09

4. Indian Society of Medical and Paediatric Oncology (ISMPO)—Breast Cancer in Young Guidelines;Indian Journal of Medical and Paediatric Oncology;2024-07-22

5. Breast cancer stage and molecular subtype distribution: real-world insights from a regional oncological center in Hungary;Discover Oncology;2024-06-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3